What is C2C Development?
C2C Development LLC operates as a specialized contract manufacturer, bridging the critical gap between initial medical device conceptualization and full-scale commercialization. As an FDA-registered and ISO 13485:2016 certified entity, the firm provides a comprehensive suite of services, including regulatory strategy, pilot production, and precision manufacturing. Their facility, equipped with controlled cleanroom environments, ensures that all outputs meet stringent quality standards for packaging, labeling, and sterilization. By offering end-to-end support—from prototyping and verification testing to final production—C2C Development serves as a vital partner for companies navigating the complex regulatory and technical hurdles inherent in the medical technology sector.
How much funding has C2C Development raised?
C2C Development has raised a total of $55K across 1 funding round:
Debt
$55K
Debt (2021): $55K with participation from PPP
Key Investors in C2C Development
PPP
Public-Private Partnership
What's next for C2C Development?
With the infusion of this recent capital, C2C Development is expected to scale its manufacturing infrastructure to meet the rising demand for high-quality medical device production. The strategic focus will likely center on enhancing its verification testing capabilities and expanding its cleanroom capacity to accommodate more complex product portfolios. As the company matures through its current growth phase, it remains committed to streamlining the path to market for innovative medical solutions, ensuring that clients can transition from design to commercial viability with greater efficiency and reduced risk. Future initiatives will likely prioritize technological upgrades to maintain its competitive edge in the highly regulated healthcare manufacturing market.
See full C2C Development company page
